Figma CEO Dylan Field had experience in leadership, but not management, when he co-founded the $19.45 billion company.

Recursion Pharmaceuticals, Inc. is rated a Sell due to cash burn, Q3 net loss of $162.25M and operational trends. Learn more ...

Recent commentary about softer U.S. travel demand has spooked Marriott's near-term outlook but not its long-term story.

Breaking problematic habits that leave us feeling trapped, isolated, and out of control is possible with awareness, tools, ...

Altria Group stock faces declining cigarette sales and legal challenges. Here's why most investors should probably look ...